Bio-Me is one of the participants in a new Nordic project that will develop personalized treatment for IBD patients.
Read More
Bio-Me, a pioneer in rapid gut microbiome analysis is announcing the opening of its gut microbiome analysis service laboratory.
Read More
Bio-Me has entered into an agreement with one of the top ten consumer healthcare companies worldwide.
Read More
Dr. Morten Isaksen, CEO of Bio-Me, has been invited to present Bio-Me and its contribution to use of information from the gut microbiome in clinical settings.
Read More
Morten Isaksen, CEO of Bio-Me, is featured on LØRN, leading Norwegian technology blog and podcast service.
Read More
Bio-Me is pleased to announce that it has been selected as the recipient of Aleap Pre-Seed Fund.
Read More
After a globally competitive process spanning two months, Bio-Me was selected as one of twelve companies to be part of Katapult Accelerator (KA) Batch 3. Read More
INNOMAG, the leading innovation magazine in Norway, has selected Bio-Me as one of the 25 most innovative new companies in Norway in 2018. Read More
The conference brings together leaders and executives from the pharmaceutical, biotech, academic, and government communities. Read More
The Prime Minister was very attentive and eager to learn how GutChek(TM) from Bio-Me, combined with information and samples from HUNT can provide better health treatment and preventative measures. Read More
Bio-Me will be presenting new results from the development of its proprietary GutCheck(TM) gut microbiome analysis platform Read More
On Wednesday 14th February, Tekna, the main national engineering society in Norway, invited its members to an evening regarding the use of Big Data in the Norwegian health innovation system. Read More
Representatives from Bio-Me attended the Grand Opening of MiNiSV at Yangzi Sci-Tech Innovation Centre, Nanjing on Friday October 20th, 2017. Read More
In a milestone agreement, Bio-Me and NTNU have signed a Collaboration Agreement, giving Bio-Me access to analyze the approximately 30,000 fecal samples that will be collected as part of the ongoing HUNT 4 study. Read More
Bio-Me became the first tenant at ShareLab, the premium laboratory hotel offered by OsloTech as part of Oslo Research Park, close to the University of Oslo and Oslo University Hospital. Read More
As part of their future plans of expansion into the North American market, Bio-Me will be attending the RESI Boston conference on Monday 25th September 2017. Read More
In a historic moment, Bio-Me signed an agreement for setting up a Joint Venture and License Agreement with MiNiSV in Nanjing, China. Read More
At the recent Microbiome Invest Forum in London, organized by Kisaco Research, Bio-Me was invited to present data from their development of GutCheck(TM), the next generation gut microbiome analysis. Read More
Morten L. Isaksen, CEO of Bio-Me, was invited to give a presentation on the future of gut microbiome analysis at the recent 4th Microbiome R&D and Business Collaboration Forum in Amsterdam 3 - 4 April 2017. Read More
Bio-Me and the University of Oslo, Department of Biosciences, Centre for Ecological and Evolutionary Synthesis (CEES) have entered into a collaboration agreement Read More
Bio-Me AS has been awarded a grant under The Programme for Regional R&D and Innovation (VRI) from the Research Council of Norway (RCN) Read More
Bio-Me AS has been selected to present at the Norwegian Investment Forum 2016, organized in partnership with DNB at DNB NXT, as part of Oslo Innovation Week. Read More
Wednesday 12th October was the official opening of Aleap - the new Health Incubator located at the Oslo Science Park, where Bio-Me AS is located. Read More
As one of only four selected companies, Bio-Me AS will present to investors and angel investors in Helsinki, Finland. Read More
Bio-Me AS will present its business case at the SeedForums investor event hosted by Carnegie Investment Bank in Stockholm 9th September 2016. Read More